Literature DB >> 20454950

Changes in short- and long-term cardiovascular risk of incident diabetes and incident myocardial infarction--a nationwide study.

M L Norgaard1, S S Andersen, T K Schramm, F Folke, C H Jørgensen, M L Hansen, C Andersson, D M Bretler, A Vaag, L Køber, C Torp-Pedersen, G H Gislason.   

Abstract

AIMS/HYPOTHESIS: We assessed secular trends of cardiovascular outcomes following first diagnosis of myocardial infarction (MI) or diabetes in an unselected population.
METHODS: All Danish residents aged > or = 30 years without prior diabetes or MI were identified by individual-level linkage of nationwide registers. Individuals hospitalised with MI or claiming a first-time prescription for a glucose-lowering medication (GLM) during the period from 1997 to 2006 were included. Analyses were by Poisson regression models. Primary endpoints were death by all causes, cardiovascular death and MI.
RESULTS: The study included 3,092,580 individuals, of whom 77,147 had incident MI and 118,247 new-onset diabetes. MI patients had an increased short-term risk of all endpoints compared with the general population. The rate ratio (RR) for cardiovascular death within the first year after MI was 11.1 (95% CI 10.8-11.5) in men and 14.8 (14.3-15.3) in women, respectively. The risk rapidly declined and 1 year after the index MI, RR was 2.11 (2.00-2.23) and 2.8 (2.64-2.97) in men and women, respectively. Patients with diabetes carried a constantly elevated risk of all endpoints compared with the general population. The cardiovascular death RR was 1.90 (1.77-2.04) and 1.92 (1.78-2.07) in men and women, respectively during the first year after GLM initiation. CONCLUSIONS/
INTERPRETATION: Incident MI is associated with high short-term risk, which decreases rapidly over time. Incident diabetes is associated with a persistent excessive cardiovascular risk after initiation of GLM therapy. This further strengthens the necessity of early multi-factorial intervention in diabetes patients for long-term benefit.

Entities:  

Mesh:

Year:  2010        PMID: 20454950     DOI: 10.1007/s00125-010-1783-z

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  33 in total

1.  Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction.

Authors:  Gunnar H Gislason; Jeppe N Rasmussen; Steen Z Abildstrøm; Niels Gadsbøll; Pernille Buch; Jens Friberg; Søren Rasmussen; Lars Køber; Steen Stender; Mette Madsen; Christian Torp-Pedersen
Journal:  Eur Heart J       Date:  2006-01-06       Impact factor: 29.983

2.  The Danish prescription registries.

Authors:  D Gaist; H T Sørensen; J Hallas
Journal:  Dan Med Bull       Date:  1997-09

3.  The Danish National Hospital Register. A valuable source of data for modern health sciences.

Authors:  T F Andersen; M Madsen; J Jørgensen; L Mellemkjoer; J H Olsen
Journal:  Dan Med Bull       Date:  1999-06

4.  Trends in the mortality burden associated with diabetes mellitus: a population-based study in Rochester, Minn, 1970-1994.

Authors:  Randal J Thomas; Pasquale J Palumbo; L Joseph Melton; Véronique L Roger; Jeanine Ransom; Peter C O'Brien; Cynthia L Leibson
Journal:  Arch Intern Med       Date:  2003-02-24

5.  Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.

Authors:  Keith A A Fox; Shamir R Mehta; Ron Peters; Feng Zhao; Nasser Lakkis; Bernard J Gersh; Salim Yusuf
Journal:  Circulation       Date:  2004-08-16       Impact factor: 29.690

6.  Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.

Authors:  Peter Gaede; Pernille Vedel; Nicolai Larsen; Gunnar V H Jensen; Hans-Henrik Parving; Oluf Pedersen
Journal:  N Engl J Med       Date:  2003-01-30       Impact factor: 91.245

Review 7.  Economic costs of diabetes in the U.S. In 2007.

Authors: 
Journal:  Diabetes Care       Date:  2008-03       Impact factor: 19.112

8.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

9.  Effect of a multifactorial intervention on mortality in type 2 diabetes.

Authors:  Peter Gaede; Henrik Lund-Andersen; Hans-Henrik Parving; Oluf Pedersen
Journal:  N Engl J Med       Date:  2008-02-07       Impact factor: 91.245

10.  Initiation and persistence to statin treatment in patients with diabetes receiving glucose-lowering medications 1997- 2006.

Authors:  H Dominguez; T K Schramm; M L Norgaard; S Z Abildstrøm; L Kober; C Jørgensen; T J Guterbaum; H E Poulsen; C Torp-Pedersen; G H Gislason
Journal:  Open Cardiovasc Med J       Date:  2009-11-12
View more
  12 in total

1.  Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes.

Authors:  C Andersson; L van Gaal; I D Caterson; P Weeke; W P T James; W Coutinho; W Couthino; N Finer; A M Sharma; A P Maggioni; C Torp-Pedersen
Journal:  Diabetologia       Date:  2012-05-26       Impact factor: 10.122

2.  Low alcohol consumption increases the risk of impaired glucose tolerance in patients with non-alcoholic fatty liver disease.

Authors:  Teruki Miyake; Teru Kumagi; Masashi Hirooka; Shinya Furukawa; Osamu Yoshida; Mitsuhito Koizumi; Shin Yamamoto; Takao Watanabe; Yasunori Yamamoto; Yoshio Tokumoto; Eiji Takeshita; Masanori Abe; Kohichiro Kitai; Bunzo Matsuura; Yoichi Hiasa
Journal:  J Gastroenterol       Date:  2016-03-12       Impact factor: 7.527

Review 3.  [Platelet aggregation inhibitors and anticoagulants during ophthalmic interventions].

Authors:  N Feltgen; H Hoerauf; W Noske; A Hager; J Koscielny
Journal:  Ophthalmologe       Date:  2016-12       Impact factor: 1.059

4.  Long-term prognostic importance of diabetes after a myocardial infarction depends on left ventricular systolic function.

Authors:  Charlotte Andersson; Gunnar H Gislason; Charlotte Mérie; Ulrik M Mogensen; Scott D Solomon; Christian Torp-Pedersen; Lars Køber
Journal:  Diabetes Care       Date:  2011-06-29       Impact factor: 19.112

5.  Treatment-dependent and treatment-independent risk factors associated with the risk of diabetes-related events: a retrospective analysis based on 229,042 patients with type 2 diabetes mellitus.

Authors:  Thomas Wilke; Sabrina Mueller; Antje Groth; Andreas Fuchs; Lisa Seitz; Joachim Kienhöfer; Ulf Maywald; Rainer Lundershausen; Martin Wehling
Journal:  Cardiovasc Diabetol       Date:  2015-02-03       Impact factor: 9.951

Review 6.  Pathophysiology of diabetic dyslipidaemia: where are we?

Authors:  Bruno Vergès
Journal:  Diabetologia       Date:  2015-03-01       Impact factor: 10.122

7.  Effectiveness of sulphonylureas in the therapy of diabetes mellitus type 2 patients: an observational cohort study.

Authors:  Thomas Wilke; Sabrina Mueller; Antje Groth; Bjoern Berg; Niklas Hammar; Katherine Tsai; Andreas Fuchs; Stephanie Stephens; Ulf Maywald
Journal:  J Diabetes Metab Disord       Date:  2016-08-02

Review 8.  Mortality and morbidity trends after the first year in survivors of acute myocardial infarction: a systematic review.

Authors:  Saga Johansson; Annika Rosengren; Kate Young; Em Jennings
Journal:  BMC Cardiovasc Disord       Date:  2017-02-07       Impact factor: 2.298

9.  Differences in cancer survival among white and black cancer patients by presence of diabetes mellitus: Estimations based on SEER-Medicare-linked data resource.

Authors:  Clara Lam; Kathleen Cronin; Rachel Ballard; Angela Mariotto
Journal:  Cancer Med       Date:  2018-05-23       Impact factor: 4.452

10.  Psoriasis and new-onset diabetes: a Danish nationwide cohort study.

Authors:  Usman Khalid; Peter Riis Hansen; Gunnar Hilmar Gislason; Jesper Lindhardsen; Søren Lund Kristensen; Signe Abitz Winther; Lone Skov; Christian Torp-Pedersen; Ole Ahlehoff
Journal:  Diabetes Care       Date:  2013-03-14       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.